- Home
- YPF vs ITCI Comparison
YPF vs ITCI Comparison
Compare YPF & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YPF
- ITCI
- Stock Information
- Founded
- YPF 1977
- ITCI 2002
- Country
- YPF Argentina
- ITCI United States
- Employees
- YPF N/A
- ITCI N/A
- Industry
- YPF Integrated oil Companies
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- YPF Energy
- ITCI Health Care
- Exchange
- YPF Nasdaq
- ITCI Nasdaq
- Market Cap
- YPF 15.9B
- ITCI 8.7B
- IPO Year
- YPF 1993
- ITCI N/A
- Fundamental
- Price
- YPF $45.00
- ITCI $126.89
- Analyst Decision
- YPF Buy
- ITCI Buy
- Analyst Count
- YPF 8
- ITCI 13
- Target Price
- YPF $37.64
- ITCI $100.31
- AVG Volume (30 Days)
- YPF 2.3M
- ITCI 2.9M
- Earning Date
- YPF 03-05-2025
- ITCI 02-20-2025
- Dividend Yield
- YPF N/A
- ITCI N/A
- EPS Growth
- YPF 426.45
- ITCI N/A
- EPS
- YPF 2.00
- ITCI N/A
- Revenue
- YPF $15,678,121,770.00
- ITCI $613,728,000.00
- Revenue This Year
- YPF N/A
- ITCI $48.41
- Revenue Next Year
- YPF N/A
- ITCI $38.26
- P/E Ratio
- YPF $25.82
- ITCI N/A
- Revenue Growth
- YPF 269.29
- ITCI 46.08
- 52 Week Low
- YPF $14.53
- ITCI $62.78
- 52 Week High
- YPF $47.43
- ITCI $128.00
- Technical
- Relative Strength Index (RSI)
- YPF 62.86
- ITCI 87.18
- Support Level
- YPF $44.20
- ITCI $80.83
- Resistance Level
- YPF $47.43
- ITCI $128.00
- Average True Range (ATR)
- YPF 1.56
- ITCI 2.57
- MACD
- YPF -0.20
- ITCI 4.45
- Stochastic Oscillator
- YPF 60.55
- ITCI 97.65
About YPF YPF Sociedad Anonima
YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. The company's upstream operations consist of the exploration, development, and production of crude oil, natural gas, and LPG. Its downstream operations include the refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG, and bio-fuels. The company generates maximum revenue from the downstream segment.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.